First Light Asset Management, LLC Invitae Corp Transaction History

First Light Asset Management, LLC

  • $1.15 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$14.7 - $28.67 $3.77 Million - $7.35 Million
-256,367 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$24.31 - $33.6 $25,549 - $35,313
1,051 Added 0.41%
256,367 $7.29 Million
Q2 2021

Aug 13, 2021
BUY
$26.09 - $40.4 $74,982 - $116,109
2,874 Added 1.14%
255,316 $8.61 Million
Q1 2021

May 17, 2021
BUY
$33.06 - $56.93 $8.35 Million - $14.4 Million
252,442 New
252,442 $9.65 Million

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email